1.
Psychiatr Clin North Am
; 45(4): 639-661, 2022 12.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36396270
RESUMO
Cognitive impairment and dementia affect dozens of millions of people worldwide and cause significant distress to patients and caregivers and a financial burden to families and health care systems. Careful history-taking, cognitive and physical examination, and supplemental neuroimaging and fluid-based biomarkers can accurately diagnose neurocognitive disorders. Management includes non-pharmacological and pharmacological treatments tailored to the etiology and to the individual.